转化糖注射液及肌氨肽苷联合应用对糖尿病并发急性脑梗死的疗效
|
摘要
目的探究转化糖注射液及肌氨肽苷联合应用对糖尿病并发急性脑梗死的疗效。方法将2013年5月至2015年8月间在我院接受治疗的80例急性脑梗死(发病时间为6小时~7天)患者为本次研究对象,对比两组患者神经功能缺损及治疗情况。结果观察组的治愈率明显高于对照组,差异显着,有统计学意义,P>0.05。结论糖尿病并发急性脑梗死患者采用转化糖注射液及肌氨肽苷联合治疗,疗效显著,不良反应小,可有效促进患者神经功能恢复,能有效降低患者的致残率,值得临床应用。
Objective Explore and invert sugar injection and muscle ammonia peptide glycosides the curative effect of combined application of diabetes complicated with acute cerebral infarction. Methods Will be between May 2013 to August 2015 in our hospital treated 80 cases of acute cerebral infarction(onset time of 6 hours to 7 days) patients as the research object, compared two groups of patients and treatment of neurologic deficits. Results The cure rate of observation group was obviously higher than that of control group, the difference significant, was statistically significant, P>0.05). Conclusions Diabetes mellitus complicated with acute cerebral infarction patients and invert sugar injection and muscle ammonia peptide glycosides treatment, curative effect is distinct, less adverse reaction, which can effectively promote patients with nerve functional recovery, can effectively reduce the morbidity of patients, worthy of clinical application.
Objective Explore and invert sugar injection and muscle ammonia peptide glycosides the curative effect of combined application of diabetes complicated with acute cerebral infarction. Methods Will be between May 2013 to August 2015 in our hospital treated 80 cases of acute cerebral infarction(onset time of 6 hours to 7 days) patients as the research object, compared two groups of patients and treatment of neurologic deficits. Results The cure rate of observation group was obviously higher than that of control group, the difference significant, was statistically significant, P>0.05). Conclusions Diabetes mellitus complicated with acute cerebral infarction patients and invert sugar injection and muscle ammonia peptide glycosides treatment, curative effect is distinct, less adverse reaction, which can effectively promote patients with nerve functional recovery, can effectively reduce the morbidity of patients, worthy of clinical application.
引文
[1]舒鑫,唐兴江.肌氨肽苷联合早期针灸及康复治疗对急性脑梗死的临床疗效观察[J].实用心脑肺血管病杂志,2013,21(4):60-62.
[2]石颖新.奥扎格雷钠联合肌氨肽苷治疗脑卒中40例[J].现代中西医结合杂志,2012,21(3):283-284..
[3]冯永新.肌氨肽苷联合丹参注射液治疗脑梗死患者的临床疗效[J].中国现代药物应用,2016,10(3):173-174..
[4]吴永红,钟妙容.肌氨肽苷联合银杏达莫注射液治疗急性脑梗死疗效观察[J].实用心脑肺血管病杂志,2012,20(7):1190-1191.
[5]杨瑞成,费云瀚,肖永红等.肌氨肽苷联合丹参对脑梗死患者神经保护及相关生化指标的影响[J].中国煤炭工业医学杂志,2015,18(2):188-191..
[6]邹桢,邹瑢.依达拉奉联合肌氨肽苷注射液治疗急性脑梗死120例疗效观察[J].青岛医药卫生,2013,45(1):54-55..
[7]卢霞,慕志杰.丹红注射液治疗急性脑梗死的效果观察[J].包头医学院学报,2015,31(9):32-33.
[8]夏恪迪,王雪莹,王莉梅等.三种脑神经保护剂治疗急性脑梗死的成本分析[J].中国继续医学教育,2016,8(6):144-145.
[9]蒙云.肌氨肽苷治疗急性脑梗死100例疗效观察[J].中国现代医药杂志,2011,13(5):99-100.DOI:10.3969/j.issn.1672-9463.2011.05.042.
[10]吕艳宁.肌氨肽苷注射液治疗急性脑梗死的疗效观察[J].当代医学,2010,16(4):133.
[2]石颖新.奥扎格雷钠联合肌氨肽苷治疗脑卒中40例[J].现代中西医结合杂志,2012,21(3):283-284..
[3]冯永新.肌氨肽苷联合丹参注射液治疗脑梗死患者的临床疗效[J].中国现代药物应用,2016,10(3):173-174..
[4]吴永红,钟妙容.肌氨肽苷联合银杏达莫注射液治疗急性脑梗死疗效观察[J].实用心脑肺血管病杂志,2012,20(7):1190-1191.
[5]杨瑞成,费云瀚,肖永红等.肌氨肽苷联合丹参对脑梗死患者神经保护及相关生化指标的影响[J].中国煤炭工业医学杂志,2015,18(2):188-191..
[6]邹桢,邹瑢.依达拉奉联合肌氨肽苷注射液治疗急性脑梗死120例疗效观察[J].青岛医药卫生,2013,45(1):54-55..
[7]卢霞,慕志杰.丹红注射液治疗急性脑梗死的效果观察[J].包头医学院学报,2015,31(9):32-33.
[8]夏恪迪,王雪莹,王莉梅等.三种脑神经保护剂治疗急性脑梗死的成本分析[J].中国继续医学教育,2016,8(6):144-145.
[9]蒙云.肌氨肽苷治疗急性脑梗死100例疗效观察[J].中国现代医药杂志,2011,13(5):99-100.DOI:10.3969/j.issn.1672-9463.2011.05.042.
[10]吕艳宁.肌氨肽苷注射液治疗急性脑梗死的疗效观察[J].当代医学,2010,16(4):133.